The purpose of this study is to determine the safety and efficacy of using Restylane Perlane to shape the nasal dorsum and/or nasal root in comparison with a no-treatment control group

Inclusion Criteria:

• Chinese origin
• Subject with desire to shape the nasal dorsum and/or nasal root
• Subjects who, in the opinion of the investigator, can achieve a clinically meaningful aesthetic correction of their nose with ≤ 1 ml Restylane Perlane

Exclusion Criteria:

• Subjects with previous nasal surgery, including grafts or implants to the nose area
• Subjects requiring filler treatment around the tip of the nose or between the eyebrows (glabella region) to achieve a good aesthetic outcome
• Subjects with a history of chronic sinusitis or rhinitis
• Subjects who have previously received aesthetic treatment in the forehead, glabellar and/or nose area with a dermal filler

During study participation, up to 12 months.

Each subject was questioned about AEs at each clinical visit starting at the treatment visit, Visit 2. The question asked was "Since your last clinical visit have you had any health problems?" Information on AEs could also be obtained from signs and symptoms detected during each examination, observations by the study personnel, reactions recorded in the subject diary that were ongoing on Day 14 or spontaneous reports from the subjects during the study.